Search
Search

The future of Public-Private-Partnerships for R&D in healthcare: will the COVID-19 experience change the game?

9 March 2021 12:00 – 13:00 CET


Tuesday 09 March 2021 from 12:00-13:00 CET

The rapid development of a range of COVID-19 vaccines during the pandemic has renewed interest in public-private partnerships. For example, governments and international agencies have partnered with private pharmaceutical companies to fund research and development programmes. How did these partnerships develop? Did their development incorporate insights from previous initiatives for outbreak management? What have been the challenges thus far and how will this experience shape future public-private partnerships for R & D in healthcare? Join us in this webinar to find out whether COVID-19 has been a game-changer.

Speakers

Barbara Kerstiëns, European Commission (keynote)

Vasee Moorthy, World Health Organization, Geneva

Magda Chlebus, European Federation of Pharmaceutical Industries and Associations (EFPIA)

Yannis Natsis, European Public Health Alliance

Facilitators

Dimitra Panteli & Erica Richardson (European Observatory on Health Systems and Policies)

This webinar is part of a series of webinars which draws lessons from country experiences based on the COVID-19 Health System Response Monitor (HSRM) - a joint undertaking with the WHO Regional Office for Europe, the European Commission and the European Observatory. The COVID-19 HSRM builds on the expertise of the Health Systems and Policy Monitor network and the WHO Country Offices and the knowledge and work of colleagues in the Regional Office and DG SANTE who are dealing with the pandemic and supporting countries. The webinar series is indebted to them all.

Webinar Recording

Click here for the recording

 

 

Subscribe to our newsletter

Sign Up